Drug Shortage Report for PROGESTERONE INJECTION, USP
Report ID | 231323 |
Drug Identification Number | 02531828 |
Brand name | PROGESTERONE INJECTION, USP |
Common or Proper name | PROGESTERONE INJECTION, USP |
Company Name | HIKMA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | PROGESTERONE |
Strength(s) | 50MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 10mL |
ATC code | G03DA |
ATC description | PROGESTOGENS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2024-07-05 |
Actual start date | |
Estimated end date | 2024-07-21 |
Actual end date | 2024-07-23 |
Shortage status | Resolved |
Updated date | 2024-07-29 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5995 AVEBURY ROAD, SUITE 804 MISSISSAUGA, ONTARIO CANADA L5R 3P9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2024-07-29 | French | Compare |
v4 | 2024-07-29 | English | Compare |
v3 | 2024-07-06 | English | Compare |
v2 | 2024-06-26 | French | Compare |
v1 | 2024-06-26 | English | Compare |
Showing 1 to 5 of 5